PODOFILOX (Paddock Laboratories, LLC)
Welcome to the PulseAid listing for the PODOFILOX drug offered from Paddock Laboratories, LLC. This Decreased Mitosis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Paddock Laboratories, LLC |
| NON-PROPRIETARY NAME: | PODOFILOX |
| SUBSTANCE NAME: | PODOFILOX |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Mitosis [PE] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2002-01-29 |
| END MARKETING DATE: | 0000-00-00 |
PODOFILOX HUMAN PRESCRIPTION DRUG Details:
| Item Description | PODOFILOX from Paddock Laboratories, LLC |
| LABELER NAME: | Paddock Laboratories, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2002-01-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0574-0611_0374a375-639c-439d-914c-538b1e790c07 |
| PRODUCT NDC: | 0574-0611 |
| APPLICATION NUMBER: | ANDA075600 |
Other PODOFILOX Pharmaceutical Manufacturers / Labelers:
